Sabra Health Care REIT director granted 8,310 RSUs

KATZMANN LYNNE S reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

KATZMANN LYNNE S reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. director Lynne S. Katzmann received a grant of 8,310 restricted stock units of Common Stock at no cash cost, as part of the company’s 2009 Performance Incentive Plan. These units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting.

Each stock unit represents the right to receive one share of common stock. Following this award, Katzmann directly holds 86,121 stock units, including 8,310 unvested units and 55,016 units that have vested but for which payment has been deferred.

Insider Trade Summary

Grant/Award: 8,310 shares

Grant/Award 1 txn

Insider KATZMANN LYNNE S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,310	$0.00	$0.00

Holdings After Transaction: Common Stock — 86,121 shares (Direct)

Footnotes (2)

1. F1. Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the date of the next annual stockholders' meeting.
2. F2. Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Key Figures

Restricted stock units granted: 8,310 units Total stock units after transaction: 86,121 units Unvested stock units: 8,310 units +2 more

5 metrics

Restricted stock units granted 8,310 units Equity award to director on June 17, 2026

Total stock units after transaction 86,121 units Direct holdings following grant

Unvested stock units 8,310 units Units from this grant subject to vesting

Vested deferred stock units 55,016 units Vested but payment deferred

Grant price per unit $0.00 per unit Equity compensation, no cash paid by director

Key Terms

restricted stock units, 2009 Performance Incentive Plan, vest, deferred

4 terms

restricted stock units financial

"Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2009 Performance Incentive Plan financial

"Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan."

vest financial

"The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027..."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

deferred financial

"Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sabra Health Care REIT (SBRA) report in this Form 4 for Lynne Katzmann?

Sabra Health Care REIT reported a grant of 8,310 restricted stock units of Common Stock to director Lynne S. Katzmann. The units were issued at no cash cost under the 2009 Performance Incentive Plan as equity-based compensation rather than as an open-market purchase.

How do Lynne Katzmann’s new restricted stock units at SBRA vest?

The 8,310 restricted stock units vest in equal monthly installments starting July 17, 2026. Vesting continues until the earlier of June 17, 2027 or the day before Sabra Health Care REIT’s next annual stockholders’ meeting, tying the award to continued board service over that period.

How many Sabra Health Care REIT stock units does Lynne Katzmann hold after this grant?

After the grant, Lynne Katzmann holds 86,121 stock units directly. This total includes 8,310 unvested restricted stock units from the new award and 55,016 stock units that have already vested but for which payment in shares has been deferred to a later date.

What does each Sabra Health Care REIT stock unit granted to Lynne Katzmann represent?

Each stock unit represents the right to receive one share of Sabra Health Care REIT common stock. When units vest and are settled, Katzmann will receive an equivalent number of common shares, aligning her compensation with the company’s long-term stock performance rather than immediate cash payments.

Is Lynne Katzmann’s Form 4 transaction in SBRA stock a market purchase or sale?

The Form 4 shows an acquisition through an equity award, not a market trade. The 8,310 shares were granted as restricted stock units at a stated price of $0.00 per share, reflecting compensation from Sabra Health Care REIT rather than an open-market buy or sell transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 06:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KATZMANN LYNNE S

(Last) (First) (Middle)

C/O SABRA HEALTH CARE REIT, INC.

1781 FLIGHT WAY

(Street)

TUSTIN CALIFORNIA 92782

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2026		A		8,310(1)	A	$0	86,121(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the date of the next annual stockholders' meeting.

2. Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Michael Costa, as Attorney-in-Fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)